« Back
Home /
Atezolizumab

Atezolizumab

Item no.	TMO-T9902-5mg
Manufacturer	TargetMol
CASRN	1380723-44-3
Amount	5 mg
Quantity options	100 mg 10 mg 1 mg 25mg 50mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	1380723-44-3
Shipping condition	Cool pack
Available
Manufacturer - Targets	PD-1/PD-L1\|\|\|Autophagy\|\|\|Apoptosis
Shipping Temperature	cool pack
Storage Conditions	-20°
Molecular Weight	145 kDa
Description	Atezolizumab is an antibody inhibitor, a humanized monoclonal antibody, IgG1, which targets PD-L1 and blocks the interaction of PD-L1 with PD-1. Atezolizumab has antitumor activity and promotes T-cells to attack tumor cells.
Pathways	Apoptosis\|\|\|Immunology/Inflammation\|\|\|Cell Cycle/Checkpoint\|\|\|Autophagy

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Delivery expected until 1/31/2025